Research news

Readmission risks after stem cell transplants

Most common reasons for readmission of patients after haematopoietic cell transplants are infections and gastrointestinal symptoms, a study shows
Picture shows a patient receiving a bone marrow autotransplant, in which high doses of chemotherapy or radiation therapy are followed by infusion of the patient’s own stem cells.

The most common reasons for readmission of patients after haematopoietic cell transplants are infections and gastrointestinal symptoms, a study shows

When patients need to be readmitted to hospital within 30 days of a stem cell transplant – which may lead to significant healthcare costs – the most common reasons are infections and gastrointestinal symptoms, a US study shows.

Such transplants are the intravenous infusion of autologous stem cells – the patient’s own cells – or allogeneic cells from a matching donor.

The procedure re-establishes the blood cell-forming tissue, function and capacity of the marrow in patients with bone marrow disorder, defects or damage.

It is associated with significant morbidity and mortality.

...

Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Cancer Nursing Practice
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?

Jobs